Detalles de la búsqueda
1.
Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulin.
Diabetes Obes Metab;
25(9): 2514-2525, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246802
2.
Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease.
Scand J Gastroenterol;
55(8): 884-890, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631131
3.
Retraction notice to "Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody" [Clin. Immunol. 113/1 (2004) 64-73].
Clin Immunol;
262: 110197, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555222
4.
HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?
Int J Cancer;
140(8): 1713-1726, 2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27870005
5.
Time Course and Clinical Implications of Development of Antibodies Against Adalimumab in Patients With Inflammatory Bowel Disease.
J Clin Gastroenterol;
50(6): 483-9, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26166141
6.
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.
Dig Dis Sci;
60(9): 2762-70, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25673037
7.
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial.
Gut;
63(6): 919-27, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23878167
8.
Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models.
J Cell Physiol;
229(12): 1918-25, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24700487
9.
Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease: post hoc analysis of a randomized controlled trial.
Am J Gastroenterol;
109(7): 1055-64, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24796769
10.
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study.
Genes (Basel);
15(5)2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38790263
11.
Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's disease.
Ther Drug Monit;
35(4): 530-8, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23765033
12.
Immunoregulation by naturally occurring and disease-associated autoantibodies : binding to cytokines and their role in regulation of T-cell responses.
Adv Exp Med Biol;
750: 116-32, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22903670
13.
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
NEJM Evid;
1(8): EVIDoa2200061, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319804
14.
The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes.
Infect Immun;
79(4): 1559-65, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21245264
15.
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
Mult Scler;
17(5): 567-77, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21177756
16.
Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease.
Scand J Gastroenterol;
46(3): 310-8, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21087119
17.
Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients.
Mult Scler;
16(8): 942-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20595247
18.
Potential use of rapamycin in HIV infection.
Br J Clin Pharmacol;
70(6): 784-93, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21175433
19.
Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
Autoimmun Rev;
19(7): 102571, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32376402
20.
Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches.
J Affect Disord;
263: 15-24, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31818772